Tissue Banking Market – Global Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024
The report cover may be different from the image shown.
The product will be delivered by email. If you have any question, want to preview some sample pages, or ask for custom research, please contact us. You can also check with us for possible discount. It is possible now to buy a part of the report in terms of chapter, section, data table or figure.
By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.
"Tissue Banking Market – Global Drivers, Restraints, Opportunities, Trends, and Forecast: 2018–2024
Overview: The conservation and banking of tissues subsequent to donor harvest is an extended medicinal area that has until lately witnessed progress. Nevertheless, in a similar way we bank stem cells, embryos and other tissues at present are likely to govern the biological time for complete tissues through approaches identical to vitrification and controlled hypothermia. A constant growth of tissues and organs scarcity has led to early deaths with consequences in enormous outlays to society. The capacity to bank tissues has an instantaneous effect on transplant medicine, surgical treatment of cancer, combat trauma, and industrial accidents.
Market Analysis: The “global tissue banking market” is estimated to witness a CAGR of 11.2% during the forecast period 2018–2024. The market is analyzed based on four segments – type, application, tissue type, and regions.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the tissue banking market, followed by Europe, Asia Pacific, and Rest of the World. More than 44.0% of the market is occupied by North America, with the US being the major contributor to the market growth.
Type Analysis: Based on types, the market is segmented into equipment and consumables. Equipment holds a dominant share in the market and is also the fastest growing segment.
Application Analysis: Based on application areas, the market is segmented into clinical application and research & development. The market is dominated by research & development.
Tissue Type Analysis: Based on tissue banking areas, the market is segmented into cardiovascular tissue, lung tissue, kidney tissue, corneal tissue, and other tissues. The corneal tissue segment is dominant among others in the market.
Key Players: The major players in the market are Thermo Fisher Scientific, Danaher Corporation, Custom Biogenic Solution, Tecan Group, and Brooks Automation, Inc.
Competitive Analysis: The tissue banking market is facing intense competition due to the presence of many players in the market. However, the majority of the market share is occupied by Thermo Fisher Scientific, Danaher Corporation, Custom Biogenic Solution, Tecan Group, and Brooks Automation, Inc. To maintain their leadership, the major players are collaborating with small players who have advanced technology. For instance, in March 2014, Brooks Automation collaborated with BioCision for the development of automated temperature-controlled technology for biobanking and sample handling. This association helped in filling the gap amongst sample handling and automation process.
Benefits: The report provides complete details about the usage and adoption rate of tissue banking in various regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:
" "Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Total Addressable Market (TAM) 8
1.3 Trends of the Market 10
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 13
3 Market Snapshot 15
3.1 Market Definition – Infoholic Research 15
3.2 Segmented Addressable Market (SAM) 15
3.3 Industry Trends 16
3.4 Related Markets 17
3.4.1 Wound Biologics 17
3.4.1.1 Trends in Wound Biologics Market 17
3.4.2 Stem Cell Banking 18
3.4.2.1 Trends in Stem Cell Banking Market 18
4 Market Outlook 20
4.1 Evolution 20
4.2 Market Segmentation 21
4.3 Porter 5 (Five) Forces 21
5 Market Characteristics 24
5.1 Market Dynamics 24
5.1.1 Drivers 25
5.1.1.1 Increasing demand for regenerative medicine 25
5.1.1.2 Advancements in Tissue Banking Technologies 25
5.1.2 Restraints 25
5.1.2.1 Stringent regulatory requirement 25
5.1.2.2 Ethical Issues 26
5.1.3 Opportunities 26
5.1.3.1 Market opportunities in Asia Pacific 26
5.1.3.2 Mergers and acquisitions 26
5.1.4 DRO – Impact Analysis 27
6 Types: Market Size and Analysis 28
6.1 Overview 28
6.2 Tissue Banking Equipment 29
6.3 Accessories and Consumables 30
7 Application: Market Size and Analysis 33
7.1 Overview 33
7.2 Clinical Application 33
7.3 Research and Development 34
8 Types: Market Size and Analysis 35
8.1 Overview 35
8.2 Cardiovascular Tissue 35
8.3 Corneal Tissue 36
8.4 Lungs Tissue 36
8.5 Kidney Tissue 37
8.6 Others Tissue 37
9 Regions: Market Size and Analysis 38
9.1 Overview 38
9.2 North America 39
9.2.1 Overview 39
9.2.2 US 39
9.2.3 Canada 39
9.3 Europe 40
9.3.1 Overview 40
9.3.2 UK 41
9.3.3 Germany 41
9.4 Asia Pacific 42
9.4.1 Overview 42
9.4.2 India 43
9.4.3 China 43
9.4.4 Japan 44
9.5 Rest of the World 45
9.5.1 Overview 45
9.5.2 Brazil 45
10 Competitive Landscape 47
11 Vendors Profile 48
11.1 Thermo Fisher Scientific, Inc. 48
11.1.1 Overview 48
11.1.2 Business Units 52
11.1.3 Geographic Presence 53
11.1.4 Business focus 53
11.1.5 SWOT analysis 54
11.1.6 Business Strategy 54
11.2 Danaher Corporation 55
11.2.1 Overview 55
11.2.2 Business Units 57
11.2.3 Geographic Revenue 58
11.2.4 Business Focus 58
11.2.5 SWOT Analysis 59
11.2.6 Business Strategies 59
11.3 Custom Biogenic Systems Inc 60
11.3.1 Overview 60
11.3.2 Business Focus 61
11.3.3 SWOT Analysis 61
11.3.4 Business Strategies 62
11.4 Brooks Automation, Inc. 62
11.4.1 Overview 62
11.4.2 Business Units 64
11.4.3 Geographic Presence 64
11.4.4 Business Focus 65
11.4.5 SWOT Analysis 65
11.4.6 Business Strategies 65
11.5 Tecan Group 66
11.5.1 Overview 66
11.5.2 Business Units 68
11.5.3 Geographic Presence 69
11.5.4 Business Focus 69
11.5.5 SWOT Analysis 70
11.5.6 Business Strategies 70
12 Companies to Watch for 71
12.1 Biolife Solutions 71
12.1.1 Overview 71
12.2 VWR Corporation 71
12.2.1 Overview 71
12.3 PHC Holdings Corporation 72
12.3.1 Overview 72
12.3.2 Key Highlights 73
12.4 Bluechiip Limited 74
12.4.1 Overview 74
12.5 Merck KGaA 74
12.5.1 Overview 74
12.6 Eppendorf AG 75
12.6.1 Overview 75
Annexure 77
Acronyms 77
" "Tables
TABLE 1 TISSUE BANKING MARKET REVENUE, BY TYPE, 2017–2024 ($MILLION) 28
TABLE 2 TEMPERATURE RANGE FOR STORAGE OF TISSUES 29
TABLE 3 CURRENT STORAGE METHODS 31
TABLE 4 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 48
TABLE 5 THERMO FISHER SCIENTIFIC: RECENT DEVELOPMENTS 49
TABLE 6 DANAHER CORPORATION: OFFERINGS 55
TABLE 7 DANAHER CORPORATION: RECENT DEVELOPMENTS 56
TABLE 8 CUSTOM BIOGENIC SYSTEMS INC: PRODUCT OFFERINGS 60
TABLE 9 CUSTOM BIOGENIC SYSTEMS INC: RECENT DEVELOPMENTS 61
TABLE 10 BROOKS AUTOMATION, INC.: OFFERINGS 62
TABLE 11 BROOKS AUTOMATION, INC.: RECENT DEVELOPMENTS 63
TABLE 12 TECAN GROUP: OFFERINGS 66
TABLE 13 TECAN GROUP: RECENT DEVELOPMENTS 66
TABLE 14 BIOLIFE SOLUTIONS.: OVERVIEW 71
TABLE 15 BIOLIFE SOLUTIONS.: RECENT DEVELOPMENTS 71
TABLE 16 VWR CORPORATION.: OVERVIEW 72
TABLE 17 VWR CORPORATION.: RECENT DEVELOPMENTS 72
TABLE 18 PHC HOLDINGS CORPORATION.: OVERVIEW 73
TABLE 19 PHC HOLDINGS CORPORATION.: RECENT DEVELOPMENTS 73
TABLE 20 BLUECHIIP LIMITED.: OVERVIEW 74
TABLE 21 BLUECHIIP LIMITED.: RECENT DEVELOPMENTS 74
TABLE 22 MERCK KGAA.: SNAPSHOT 75
TABLE 23 MERCK KGAA.: RECENT DEVELOPMENTS 75
TABLE 24 EPPENDORF AG: OVERVIEW 76
TABLE 25 EPPENDORF AG.: RECENT DEVELOPMENTS 76
" "Charts
CHART 1 RESEARCH METHODOLOGY 13
CHART 2 TISSUE BANKING MARKET REVENUE, 2018-2024 ($MILLION) 16
CHART 3 EVOLUTION OF TISSUE BANKING 20
CHART 4 TISSUE BANKING MARKET SEGMENTATION 21
CHART 5 PORTERS 5 FORCES ON TISSUE BANKING MARKET 21
CHART 7 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES 24
CHART 8 DRO - IMPACT ANALYSIS OF TISSUE BANKING MARKET 27
CHART 1 TISSUE BANKING MARKET SEGMENT REVENUE BY TYPE, 2017 VS 2024 ($ MILLION) 28
CHART 2 TISSUE BANKING EQUIPMENTS MARKET REVENUE, BY TYPES 2017-2024 ($MILLION) 30
CHART 3 TISSUE BANKING ACCESSORIES AND CONSUMABLES MARKET REVENUE, BY TYPE 2017-2024 ($MILLION) 31
CHART 4 TISSUE BANKING MARKET SEGMENT REVENUE BY TYPE, 2017 VS 2024 ($ MILLION) 33
CHART 5 TISSUE BANKING MARKET SEGMENT REVENUE BY TYPE, 2017 VS 2024 ($ MILLION) 35
CHART 6 TISSUE BANKING MARKET BY REGIONAL SEGMENTATION, 2017 (%) 38
CHART 7 TISSUE BANKING MARKET REVENUE IN NORTH AMERICA, 2017-2024 ($MILLION) 40
CHART 8 TISSUE BANKING MARKET REVENUE IN EUROPE, 2017-2024 ($MILLION) 41
CHART 9 TISSUE BANKING MARKET REVENUE IN ASIA PACIFIC, 2017-2024 ($MILLION) 44
CHART 10 TISSUE BANKING REVENUE IN REST OF THE WORLD, 2017-2024 ($MILLION) 45
CHART 11 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 51
CHART 12 THERMO FISHER SCIENTIFIC INC: BUSINESS UNITS 52
CHART 13 THERMO FISHER SCIENTIFIC, INC.: GEOGRAPHIC PRESENCE 53
CHART 14 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS 54
CHART 15 DANAHER CORPORATION: OVERVIEW SNAPSHOT 56
CHART 16 DANAHER CORPORATION: BUSINESS UNITS 57
CHART 17 DANAHER CORPORATION: GEOGRAPHIC REVENUE 58
CHART 18 DANAHER CORPORATION: SWOT ANALYSIS 59
CHART 19 CUSTOM BIOGENIC SYSTEMS INC: SWOT ANALYSIS 61
CHART 20 BROOKS AUTOMATION, INC.: OVERVIEW SNAPSHOT 63
CHART 21 BROOKS AUTOMATION, INC.: BUSINESS UNITS 64
CHART 22 BROOKS AUTOMATION, INC.: GEOGRAPHIC PRESENCE 64
CHART 23 BROOKS AUTOMATION, INC.: SWOT ANALYSIS 65
CHART 24 TECAN GROUP: OVERVIEW SNAPSHOT 67
CHART 25 TECAN GROUP: BUSINESS UNITS 68
CHART 26 TECAN GROUP: GEOGRAPHIC PRESENCE 69
CHART 27 TECAN GROUP: SWOT ANALYSIS 70
"